CEO of Meta-IQ
Professor Søren Nielsen MD. dr.med., CEO of Meta-IQ
Professor Søren Nielsen, MD, dr.med. is one of the world’s leading scientists in the field of cellular/molecular biology, physiological and pathological studies of aquaporins, sodium channels and transporters with more than 400 articles published. He brings to Meta-IQ invaluable business knowledge through Action Pharma A/S where he was co-founder and Executive (CEO 2001-2010, COO 2010-2012) and raised EUR 30 million to conduct clinical trials (Phase 2a & 2b) with AP214 – a candidate for acute renal failure – in Europe and the United States. AP214 was acquired in May 2012 by Abbott, Chicago (~ $ 110 million). He was also founder and CEO of 2A Pharma which is currently in clinical stage development. For his research, he has received several awards, including the Novo Nordisk Prize, the Novo Nordisk Foundation 2009.